3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
2
Lymphoma
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Neoplasms
1
Medical Oncology
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Fasting
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Anastomotic Leak
1
Interventions
Capecitabine
29
Oxaliplatin
28
Fluorouracil
16
Radiotherapy
15
Drug Therapy
11
Leucovorin
10
Bevacizumab
10
Surgical Procedures, Operative
9
Chemoradiotherapy
8
Radiation
7
sintilimab
6
Consolidation Chemotherapy
6
tislelizumab
5
spartalizumab
5
Specimen Handling
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
XELOX
4
Neoadjuvant Therapy
4
Endoscopy
4
Cetuximab
4
Biopsy
4
toripalimab
3
pembrolizumab
3
irinotecan sucrosofate
3
X-Rays
3
Radiotherapy, Intensity-Modulated
3
Proctectomy
3
Mastectomy, Segmental
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Rectal Neoplasms
×
Diet
×
Clear all
NCT07494201
2026-03-27
MIMICC
Fondazione del Piemonte per l'Oncologia
Phase NA
Recruiting
2,500 enrolled